Prevalence of undiagnosed diabetes and pre-diabetes among hypertensive patients attending Kiambu district Hospital, Kenya: a cross-sectional study by Meme, Nkatha et al.




Prevalence of undiagnosed diabetes and pre-diabetes among hypertensive patients 
attending Kiambu district Hospital, Kenya: a cross-sectional study 
 
Nkatha Meme1,&, Samuel Amwayi1, Ziporrah Nganga2, Esther Buregyeya3 
 
1Field Epidemiology Training Program, Ministry of Health, Kenya, 2Jomo Kenyatta University of Science and Technology, Kenya, 3Makerere 
University, College of Health Sciences School of Public Health, Uganda 
 
&Corresponding author: Nkatha Meme, Field Epidemiology Training Program, Ministry of Health, Kenya 
 
Key words: Diabetes, pre-diabetes, glycated haemoglobin, hypertensive patients 
 
Received: 01/07/2015 - Accepted: 20/10/2015 - Published: 24/11/2015 
 
Abstract  
Introduction: Hypertension (HTN) and diabetes mellitus (DM) are two common non-communicable diseases (NCDs) that are closely linked: one 
cannot be properly managed without attention to the other. The aim of this study was to determine the prevalence of undiagnosed diabetic and 
pre-diabetic states that is abnormal glucose regulation (AGR) and factors associated with it among hypertensive patients in Kiambu Hospital, 
Kenya. Methods: We conducted a cross-sectional study from February 2014 to April 2014. Hypertensive patients aged ≥18 attending the out-
patient medical clinic were included in the study. Pregnant and known diabetic patients were excluded. Data was collected on socio-demographics, 
behavior, and anthropometrics. Diabetes status was based on a Glycated Haemoglobin (HbA1C) classification of ≥6.5% for diabetes, 6.0-6.4% for 
pre-diabetes and ≤6.0% for normal. AGR was the dependable variable and included two diabetic categories; diabetes and pre-diabetes. 
Results: We enrolled 334 patients into the study: the mean age was 59 years (Standard deviation= 14.3). Of these patients 254 (76%) were 
women. Thirty two percent (107/334; 32%) were found to have AGR, with 14% (46) having un-diagnosed DM and 18%(61) with pre-diabetes. 
Factors associated with AGR were age ≥45 (OR = 3.23; 95% CI 1.37 ≥ 7.62), basal metabolic index (BMI) ≥ 25 Kg/m2 (OR= 3.13; 95% CI 1.53 - 
6.41), low formal education (primary/none)(OR= 2; 95%CI 1.08 - 3.56) and family history of DM (OR=2.19; 95%CI 1.16 - 4.15). 
Conclusion: There was a high prevalence of undiagnosed AGR among hypertensive patients. This highlights the need to regularly screen for AGR 
among hypertensive patients as recommended by WHO. 
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Introduction 
 
In 2012 non-communicable diseases (NCDs) were responsible for 
68% of deaths globally and almost three quarters of these deaths 
(28 million), occurred in low- and middle-income countries [1]. It is 
well known that hypertension (HTN) and diabetes mellitus (DM) are 
two common NCDs that are closely linked: one cannot be properly 
managed without attention to the other [2-4]. The presence of 
hypertension substantially increases the risk of morbidity from 
several diseases, particularly cardiovascular diseases andDM. 
Therefore targeted screening for identification of risk factors, early 
detection and timely treatment can significantly reduce morbidity 
and mortality related to these NCDs [3]. The World Health 
Organization (WHO) recommends that patients presenting with HTN 
should have a cardiovascular risk assessment, including blood 
glucose testing [1,4]. 
  
Majority of diabetic patients go through a pre-diabetes phase for 
several years [5-8], during which there is an opportunity to identify 
them and initiate timely prevention. Pre-diabetes is an intermittent 
stage of overt diabetes where the blood glucose level is higher than 
the normal value but not high enough to meet the criteria for the 
diagnosis of diabetes mellitus [7,9]. It is characterized by a fasting 
plasma glucose (FPG) level of 6.1-6.9mmol/l and/or from an Oral 
Glucose Tolerance Test (OGTT) as a 2-hour post-load plasma 
glucose level of 7.8-11mmo/l (Impaired Glucose Tolerance (IGT) 
[10] or glycated haemoglobin A1C (HbA1C) level of 5.7-6.4% [11] 
or 6.1 - 6.4% [12-14]. Pre-diabetes increases the risk of diabetes 
mellitus in hypertensive patients and both undiagnosed pre-diabetes 
and diabetes are associated with diabetic complications [15,16]. 
  
Abnormal glucose regulation (AGR) is a term used to definethe two 
glycometabolic states, that is diabetes mellitus and pre-diabetes [7]. 
In most studies AGR assessment is based on random blood sugar, 
FPG, OGTT. However, studies have shown that use of HbA1c is a 
convenient alternative test [17-19] as it is highly standardized, 
exhibits low intra-individual variation, can be obtained at any time, 
requires no patient preparation, and samples are relatively stable at 
room temperature after collection [20,21]. There is also a strong 
correlation between average plasma glucoseand HbA1C in predicting 
diabetes development in patients with cardiovascular disease such 
as hypertension, coronary artery disease and stroke [22-27]. 
  
According to WHO recommendations hypertensive patients are to 
undergo diabetes screening based on their risk profile [28]. The 
American Diabetes Association (ADA) recommends that adults at 
normal risk for diabetes undergo screening every 3 years and adults 
at high-risk based on a family history of the disease, hypertension, 
overweight or obesity, or other factors of diabetes undergo 
screening every 1 to 2 years [29]. However the optimal universally 
acceptable interval for diabetes screening of healthy adults or adults 
with hypertension or hyperlipidemia is not known according the U.S. 
Preventive Services Task Force (USPSTF) [30]. Clinical judgment 
and risk profile of the patientshould determine when to screen 
individual patients for diabetes [29,30]. One-third of all people with 
diabetes may be undiagnosed and more than 60% of newly 
diagnosed diabetics are unaware of their condition until 
complications appear [3,31-33]. According to data from the 2011 
Minnesota behavioral risk factor surveillance system, 30% of 
hypertensive adults had not received a blood glucose test within the 
previous 3 years. Among them, 10.7% had pre-diabetes and 19.6% 
had undiagnosed diabetes [34]. A cross sectional study conducted 
among hypertensive patients at Mulago National Referral Hospital, 
Uganda in 2012 found AGR in 237 (74%) patients - 50% were pre-
diabetic and 24% were undiagnosed diabetic [35]. Failure to screen 
for AGR among hypertensive patients and lack of awareness about 
the importance of screening by health providers may indicate 
missed opportunities for early detection, clinical management, and 
prevention of diabetes [34]. 
  
There is scarcity of documented data on prevalence of AGR among 
high risk groups, such as hypertensive patients in clinical settings in 
Kenya. Therefore, the aim of this study was to determine the 
prevalence of undiagnosed diabetic and pre-diabetic states and 






Design and study setting 
  
We conducted a cross sectional study from February 2014 to April 
2014 among hypertensive patients attending the out-patient medical 
clinic in Kiambu District Hospital, in Kiambu County, Kenya. Kiambu 
Sub-county is a predominantly rural area but is experiencing a rise 
inthe urban population because it borders Nairobi, the capital city of 
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Kenya to the north. Kiambu Hospital is a high volume district 
hospital that offers general in-patient and out-patient services with 
a catchment population of about 101,596 and bed capacity of 316 
and 67 cots.The hospital holds an out-patient medical clinic once a 
week. Patients enrolled into this clinic comprise of patients with HTN 
and other medical conditions. Patients are seen on appointment 
scheduled on average every 2-3 months depending on their medical 
condition for routine checkup and drug refill. At every visit routine 
tests include blood pressure (BP) reading and basal metabolic rate 
(BMI) calculations. Diabetes testing is done at the initial visit. Any 
subsequent diabetes tests are requested based on the patients 
presenting symptoms at the time of the visit and discretion of the 
clinician. 
  
Study population and participant selection 
  
Hypertensive patients aged 18 years and above who were not 
known diabetic patients attending an out-patient medical clinic were 
included in the study. Pregnant and known diabetic patients were 
excluded from the study. Eligible participants were asked to 
participate in the study as they visited the medical out-patient clinic. 
  
Sample size calculation and sampling 
  
Using the Cochran formula[36] our calculated sample size was 334 
hypertensive patients, assuming a 74% prevalence of undiagnosed 
diabetes among the hypertensive patients [35] with a 95% 
confidence intervaland 10% adjustment for non-response. 
Patientswereselected usingsystematic sampling, with every third 
hypertensive patient enrolled into the study. 
  
Data collection and study variables 
  
We utilized a structured questionnaire adapted from the WHO 
STEPS instrument for collecting surveillance data for non-
communicable diseases (NCD's) for this study [37]. The 
questionnaire was pre-tested and administered by a trained medical 
healthworker. Social demographics and behaviouralvariables such as 
age, sex, level of education, occupation, tobacco use, alcohol 
consumption, physical activity and diet were collected.Physical 
activity was assessed by asking participants if they undertook 
“vigorous-intensity activities” (e.g.lifting heavy loads, cutting 
firewood, digging, construction work, etc) and “moderate-intensity 
activities” (e.g. brisk walking, carrying light loads, milking cows, 
washing clothes, riding a bicycle, light recreational activities,etc)in a 
typicalweek. Pictorial showcards were used to describe these 
activities to participants. Time spent on these activities in a typical 
week was recorded. Participants were classified into those that met 
the WHO minimum recommendations for physical activity (at least 
75 minutes of vigorous-intensity, or 150 minutes of moderate-
intensityactivities per week) and those that did not[38]. In addition, 
history of anti-hypertensive medication, prior diabetes evaluation 
and family history of DM among the 1st degree relatives,[39] was 
collected. The outcome variable was AGR. 
  
Physical assessments included blood pressure, height, weight, waist 
and hip circumference measurements and calculation of body mass 
index (BMI) and waist-hip ratio, as detailed in a study by Ayah et al 
[40]. Body mass index (BMI), calculated as weight (kg)/height (m2) 
was used as a measure of total body obesity: BMI<18.5 was 
recorded as underweight; 18.5-24.9 as normal; 25-29.9 as 
overweight; and >30 as obese. Waist-hip ratio (waist 
circumference/hip circumference) was used as a measure of 
central/abdominal obesity: >0.85 in women and >0.95 in men.The 
waist circumference was measured using a flexible tape-measure. 
Measurement was made in the mid-axillary line midway between the 
last rib and the superior iliac crest and the recording was at the 
point of normal expiration. The hip measurement was made using a 
flexible tape-measure placed horizontally at the point of maximum 
circumference over the buttocks. Measurement was made to the 
nearest 0.5 cm. Height was measured with the subject standing 
upright against a wall on which was affixed a height measuring 
device. Measurements were made with the subject barefoot, 
standing with the back against the wall and head in the Frankfort 
position with heels together. The subject was asked to stretch to 
the fullest and then exhale. When appropriately positioned, the 
measurements were taken to the nearest 0.5 cm. Weight 
measurements were taken on a pre-calibrated weighing scale. 
Subject was weighed while dressed in light clothing and barefoot. 
Measurements were made to the nearest 0.5 kg [40]. 
  
Blood pressure (BP) was measured using a mercury 
sphygmomanometer blood pressure device (Reisterdiplomat-
presameter®). The Seventh Report of the Joint National Committee 
guideline for hypertension measurement and management was used 
[41]. Three intermittent readings were taken with the BP machine 
cuff placed mid - arm and an average of the last two readings used 
for the study. Hypertension was defined as systolic BP ≥ 140 mmHg 
and/or diastolic BP ≥ 90 mm Hg or use of prescribed anti-
hypertensive medication [2]. 
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A blood sample was collected from each study participant by 
drawing 2ml by venipuncture into an Ethylenediaminetetraaceticacid 
(EDTA) bottle and the HbA1C measured using a National 
Glycoheamoglobin Standardization Program (NGSP) analyser (Roche 
Cobas®Integra HbA1c Analyser) in a NGSP accredited 
laboratory.Classification of abnormal glucose regulation (AGR) was 
based on the revised WHO criteria and studies suggesting HbA1c 
cut-off points with high specificity and sensitivity for pre-diabetes 
screening [12,13,32]. HbA1C was grouped into diabetic HbA1c 
≥6.5 %, pre-diabetic HbA1c of 6.1 % - 6.4% and non-diabetic 
HbA1c <6.1%. AGR included two categories 1) those with diabetes 
(participants with HbA1c ≥6.5 %) and 2) those with pre-diabetes 
(participants with a HbA1c of 6.1 % - 6.4%). 
  
Data management and analysis 
  
Data was entered into version 3.5.4 of Epi-Info (CDC, Atlanta, USA) 
and analysed. Specific descriptive variables were analysedusing 
frequencies, proportions and means to describe the social-
behavioural and clinical characteristics. Bivariate analysis using Chi-
square testwere performed. Bivariate and multivariable analysis 
using logistic regressionwas used to explore the factors associated 
with AGR. An association was considered significant at P<0.05and 
95% confidence intervals (CI). Variables that had a P value ≤0.2 at 
bivariate level were included in the multivaria blelogistic analysis 
model with backward elimination to find independent factors that 




The study protocol was reviewed and approved by the Kenyatta 
National Hospital (KNH) Ethical Review Committee and 
administrative clearance sought from Kiambu District Hospital 
administration. We obtained written informed consent from each 
study participant after giving a detailed explanation of the purpose, 
risks and benefits of the study. Participants were contacted and 
given their results. Those with an AGR category of newly diagnosed 
diabetes were referred to the diabetic clinic for further management 
and follow-up while those with pre-diabetes were put on lifestyle 






Socio-behavioralcharacteristics of participants 
  
We enrolled 334 hypertensive patients into the study: the mean age 
was 58.6 years (Standard deviation = 14.3). Seventy six percent 
(254/334) were women, 38.9% (133/334) had no formal 
education, Table 1. Almost all the participants (97%; 323/334) 
reported not smoking tobacco at the time of the interview and 70% 
(232/334) had never consumed alcohol in their life time. Over half 
(56.3%; 188/334) of the respondents had truncalobesity and 40 % 
(134/334) were found obese according to their BMI, Table 2. 
Almost a quarter of the respondents (21.3%-71/334) reported a 
history of familial diabetes. 
  
Prevalence of AGR and determinants 
  
More than a third (32%; 107/334) of the participants had AGR 
(diabetes and pre-diabetes). Fourteen percent (46/334) of the 
participants were newly diagnosed as diabetic (HbA1C of ≥ 6.5%); 
while 18 % (61/334) were pre-diabetic (HbA1C of 6.1 % - 6.4%). 
Sixty eight percent (137/334) of the participants reported ever been 
screened for DM in the hypertension clinic. On bivariate analysis 
AGR was significantly associated withage ≥ 45 years (Odds Ratio 
(OR) = 4.57; (95%CI 2.00 - 10.42), BMI ≥ 25 Kg/m2 (OR= 3.35; CI 
1.68 - 6.67), lowformal education (primary/none) (OR 2.23; 95%CI 
1.27 - 3.86) and history of a first degree relative with DM (OR=2; 
95%CI 1.11- 3.16). Having a controlled blood pressure below 
140/90 mmHg was protective AGR (OR = 0.59; 95%CI 0.38-
0.95), Table 3. On multivariate analysis, age ≥ 45 (OR = 3.23; 
95% CI 1.37 - 7.62), BMI ≥ 25 Kg/m2 (OR= 3.13; 95% CI 1.53 - 
6.41), low formal education (primary/none) (OR= 2; 95%CI 1.08 - 
3.56) and history of a first degree relative with DM (OR=2.19; 
95%CI 1.16 - 4.15) were significantly associated with AGR,Table 3. 
Controlled blood pressure was significantly associated with normal 





This study aimed to determine the prevalence of undiagnosed 
diabetic and pre-diabetic states and factors associated with AGR 
among out-patient hypertensive patients in a clinical setting in 
Kenya. More than a third (32%) of the study participants had AGR 
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i.e. diabetes and pre-diabetes. Fourteen percent were newly 
diagnosed with DM, while 18% were pre-diabetic. Sixty eight 
percent of the participants reported ever been screened for DM in 
the hypertension clinic. Risk factors for AGR were being 45 years 
and above, BMI>25 kg/m2, low formal education and history of 
familial diabetes. Controlled blood pressure reduced the risk of 
developing AGR. 
  
Our study found a high prevalence of AGR (diabetes and pre-
diabetes) among hypertensive patients in the clinical setting. This is 
higher than population based studies previously done in Kenya 
which have a prevalence rangeof 3.3%to 6% [40,42]. 
Accumulating evidence reveals that AGR is common among patients 
with cardiovascular diseases in hospital settings. In Uganda, Mutebi 
et al screened 320 hypertensive patients and found 50% were pre-
diabetic and 24% were undiagnosed diabetic[35].Kidney et al 
demonstrated out of 3847 hypertensive patients in Minnesota 
10.7% had pre-diabetes and 19.6% had undiagnosed diabetes 
[34]. The Euro Heart Survey on diabetes and the heart 
demonstrated that AGR is more common than normal glucose 
metabolism in patients with coronary artery diseases and 
hypertension as 36% had pre-diabetes and 22% had newly 
detected diabetes [43]. In Germany, Luders et al found out of 260 
hypertensive patients 39% had impaired glucose tolerance and 12% 
had diabetes mellitus [44]. 
  
Our findings show that AGR is significantlyassociated with age over 
45 years and BMI above 25. Similar findings of high BMI and older 
age were demonstrated in parts of the world such as Nigeria [5], 
Uganda [6,35] and in Germany [44]. Having a low level of 
education was associated with AGRin our study. In European 
countries with lower levels of education have been used as 
predictors of DM as this is comparable and similar to social 
economic status [45-47]. Our study showed that a family history of 
diabetes was also a risk factor for glucose intolerance among 
hypertensives and similar findings were demonstrated by Mutebi et 
al [35] and Hilding et al [39]. Our study found patients with 
controlled blood pressure had reduced risk of developing AGR. A 
study done by the U.S. Preventive Services Task Force 
(USPSTF)evidenced that lowering blood pressure below 
conventional target blood pressure values reduces the incidence of 
clinically detected diabetes [30]. 
  
In contrast tobacco use, alcohol use and inadequate physical activity 
were not associated with AGR in our study and could be due to the 
small sample size of the study. The study found that tobacco use 
and harmful alcohol use was not common practice among the study 
participants as 97% did not smoke tobacco, 89% had never smoked 
tobacco in the past and 70% had never consumed alcohol. This 
finding in variation may have been due to the sample size and the 
fact that our study subjects were skewed towards a predominantly 
female population. 
  
There is evidence that the prevalence of AGR is high among 
hypertensive patients with specific risk factors, therefore a strong 
justification for use of targeted diabetic screening as it offers the 
patients and healthcare providers an opportunity to modify long-
term risk before serious complications occur [6,8,48,49]. Patients 
with newly diagnosed DM will benefit from proper glycemic control 
and reduction of complications and those with pre-diabetes will 
benefit from strategies tailored to prevent or retard onset of 
diabetes This also reduces the health costs associated with 
management of their hypertensive condition and possible 
concurrent type 2 diabetes mellitus[5,6]. Though WHO 
recommends that patients with HTN be screened for diabetes, there 
are no guidelines on how this screening should be carried out. 
Specifically, how often they should be screened and criteria for risk 
groups to be targeted. Therefore, there is need for the Ministry of 
Health to develop guidelines to guide frontline health workers on 
how to implement screening for DM and among patients with HTN 
in order to achieve early diagnosis and timely 
treatment/interventions to be able to reduce morbidity and 
mortality. 
  
Limitations are that the study findings can't be generalized to the 
population as this was a hospital based cross-sectional study. The 
study didn't collect information on the duration of hypertension 
diagnosis and the specific antihypertensive medication used by 
participants. It is known that various antihypertensive drugs have 
different effects on glucose metabolism such as thiazide diuretics 
and B blockers [50,51]. However a study in Nigeria showed that 
anti-hypertensive drugs that affected glucose metabolism didn't 
significantly affect the prevalence of pre-diabetic states in 
hypertensive patients [5,52]. The study findings would have been 
strengthened by availability of dietary and socio-economic data. Our 
physical activity data may suffer from the limitation of recall bias 
and being self- reported, even though the STEPS questionnaire has 
been validated in different populations. The study was not able to 
determine if patients had heamoglobinopathies or were taking 
medication that would lead to an underestimation or overestimation 
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of the HbA1c results, however HbA1C provides flexibility in DM 
testing as it can be performed in a non-fasting stateat any time of 
the day, and therefore maybe more convenient for both healthcare 





There was a high prevalence of undiagnosed AGR among 
hypertensive patients on follow-up. This highlights the need to 
regularly screen for AGR among hypertensive patients as 
recommended by WHO [28]. Using targeted screening based on 
risk profile to determine diabetic status offers patients and 
healthcare providers an opportunity to modify long-term risk before 
serious complications occur.There is need to have clear guidelines to 
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Table 1: Socio-demographic characteristics of hypertensive adults at Kiambu Hospital, Kenya by glucose regulation status (N=334) 
  
Diabetic           n 
(%) 
Pre-Diabetic   n 
(%) 
Normal         n 
(%) 
All Participants N 
(%) 
Sex 
    
    Male 7  (15.2) 13  (21.3) 60  (26.4) 80     (24) 
    Female 39  (84.8) 48  (78.7) 167  (73.6) 254     (76) 
Age group in years 
    
   25 - 44 3    (6.5) 4    (6.6) 55  (24.2) 62  (18.6) 
   45- 64 16  (34.8) 25     (41) 99  (43.6) 140  (41.9) 
   65 - 84 23     (50) 32  (50.8) 66  (29.1) 120  (35.9) 
   85 and above 4    (8.7) 1    (1.6) 7    (3.1) 12    (3.6) 
Level of education completed   
   
    None 27  (58.7) 31  (50.8) 75  (33.1) 133  (39.8) 
    Primary 9  (19.6) 19  (31.7) 72  (31.7) 100  (29.9) 
    Secondary (4 years) 9  (19.6) 7  (11.5) 67  (29.5) 83  (24.9) 
    University/college(2-4  years) 1    (2.2) 4    (6.6) 13    (5.7) 18    (5.4) 
Ethnicity 
    
    Kikuyu 43  (93.5) 59  (96.7) 208  (91.6) 310  (92.8) 
   Others 3    (6.5) 2    (3.3) 19    (8.4) 24   (4.2) 
Marital status 
    
    Currently married 23     (50) 36    (59) 145  (63.9) 204  (61.1) 
    Divorced 2    (4.3) 3   (4.9) 8    (3.5) 13    (3.9) 
    Never married 3    (6.5) 4   (6.6) 34     (15) 41  (12.3) 
    Widowed 18  (39.1) 18 (29.5) 40  (17.6) 76  (22.8) 
Occupation 
    
    Small scale farmer 23  (50) 31  (51) 75  (33) 129  (39) 
    Unemployed 10  (22) 11 (18) 48  (21) 69  (21) 
    Skilled formal 3      (7) 3    (5) 21    (9) 27    (8) 
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Table 2: Behavioral and anthropometric characteristics of hypertensive patients at Kiambu Hospital, Kenya by glucose regulation 
status (N=334) 
  
Diabetic           n 
(%) 
Pre-Diabetic   n 
(%) 
Normal         n 
(%) 
All Participants N 
(%) 
Currently smoke tobacco (N=334) 
    
    Yes 2    (4.3) 0 (0) 9      (4) 11    (3.3) 
    No 44  (95.7) 61  (100) 218    (96) 323  (96.7) 
Smoked tobacco in the past 
(N=323)     
    Yes 2       (4) 4    (6.6) 22    (10) 28    (8.4) 
    No 42     (96) 57  (93.4) 197    (90) 296  (88.9) 
Ever consumed Alcohol(N=334) 
    
    Yes 13  (28.3) 14    (23) 75    (33) 102  (30.5) 
    No 33  (71.7) 47    (77) 152    (67) 232  (69.5) 
Adequate Physical Activity 
    
    Yes 25     (54) 39    (64) 148    (65) 212     (64) 
    No 21     (46) 22    (36) 79    (35) 122     (36) 
Truncal Obesity 
    
    Yes 30  (65.2) 32  (52.5) 126  (55.5) 188  (56.3) 
    No 16  (34.8) 29  (47.5) 101  (44.5) 146   (43.7) 
BMI kg/m2 
    
    Underweight(<18.5) 0    (0.0) 1    (1.6) 1    (0.4) 2    (0.6) 
    Normal        (18.5-24.9) 5  (10.9) 5    (8.2) 62  (27.3) 72  (21.6) 
    Overweight (25-29.9) 18  (39.1) 21  (34.4) 87  (38.3) 126  (37.7) 
    Obese         (≥ 30) 23  (50.0) 34  (55.7) 77  (33.9) 134  (40.1) 
On prescribed HTN medication 
(N=297)     
    Yes 38  (88.4) 54  (96.4) 178  (89.9) 270  (90.9) 
    No 5  (11.6) 2   (3.6) 20  (10.1) 27    (9.1) 
Blood sugar measured in the past 12 
months     
    Yes 21  (70.0) 29    (69) 87  (66.9) 137  (67.8) 
    No 9  (30.0) 13    (31) 43  (33.1) 65  (32.2) 
Family Member with diabetes 
    
    Yes 13  (28.3) 17   (27.9) 41  (18.1) 71  (21.3) 
    No 33  (71.7) 44   (72.1) 181  (79.7) 258  (77.2) 
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Table 3: Factors associated with Abnormal Glucose Regulation (AGR) among participants, Kiambu Hospital, Kenya 
Variable 
AGR         N 
(Col%) 




Adjusted OR (95%CI) P Value 
Age ≥ 45 years 
     
    Yes 100 (94) 172 (75) 4.57 (2.00 - 10.42) 3.23 (1.37 - 7.62) 0.0074 
    No 7 55 
   
Level of Education 
     
    None/primary 86 (80) 147 (65) 2.23 (1.27 - 3.86) 2.0 (1.08 - 3.56) 0.027 
    Secondary/Tertiary 21 80 
   
BP(SBP or DBP)controlled 
     
    Yes 51 (48) 137 (60) 0.59 (0.38 - 0.95) 0.59 (0.36 - 0.97) 0.037 
    No 56 90 
   
BMI 
     
    ≥ 25kg/m2 96 (90) 164 (72) 3.35 (1.68 - 6.67 ) 3.13 (1.53 - 6.4) 0.0017 
< 25kg/m2 11 63 
   
First degree relative with  DM 
     
    Yes 25 (23) 30 (13) 2  (1.11 - 3.16) 2.19 (1.16 - 4.15) 0.011 
    No 82 197 
   
Truncal Obesity 
     
    Yes 62 (57.9) 126 (55.5) 1.1  (0.69 - 1.76) - - 
    No 45 101 
   
Gender 
     
    Female 37 (81) 167 (74) 1.56 (0.89 - 2.76) - - 
    Male 20 60 
   
Employment 
     
    Formal 6 (7) 21 (12) 0.56 (0.22 - 1.45) - - 
    Informal 80 158 
   
Marital status 
     
    Married 59 (55) 145 (64) 0.7  (0.44 - 2.76) - - 
    Not Married 48 82 
   
Tobacco Use 
     
    Yes 8 (8) 30 (13) 0.53 (0.23 - 1.20) - - 
    No 99 197 
   
Harmful alcohol consumption 
     
    Yes 80 (75) 152 (67 1.46 (0.87 - 2.45) - - 
    No 27 75 
   
Adequate physical activity 
     
 Yes 64 (60) 148 (65) 0.79 (0.49 - 1.27) - - 
No 43 79 
   
Glucose level ever measured 
     
    Yes 72 (67) 130 (57) 1.53 (0.94 - 2.49) - - 
    No 35 97 
   
Glucose level measured in  past 
12mths      
    Yes 50 (69) 87 (67) 1.12 (0.06 - 2.08) - - 
    No 22 43 
   
  
